Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
ConclusionPredicting the occurrence of RAIR-disease in DTC patients may allow clinicians to focus on systemic redifferentiating strategies and/or local treatments for metastatic lesions rather than pursuing with ineffective RAI-therapies.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Endocrinology | Statistics | Study | Thyroid | Thyroid Cancer